Biochemical Reagents

Biochemical Reagents Market Outlook

The global biochemical reagents market is projected to reach approximately USD 54 billion by 2035, growing at a CAGR of around 7% during the forecast period from 2025 to 2035. This impressive growth is driven by an increasing demand for biochemical research in diverse fields such as drug discovery, clinical diagnosis, and agricultural biotechnology, which are vital for advancements in healthcare and environmental sustainability. Rising investments in biotechnology and pharmaceutical research, as well as growing public and private funding for research initiatives, are also significantly contributing to market expansion. Additionally, technological advancements in reagent manufacturing processes and the introduction of high-throughput screening methods are expected to further bolster market growth. The integration of automation in laboratories and increasing collaborations between research institutions and pharmaceutical companies are set to enhance the efficiency and efficacy of biochemical assays and analyses.

Growth Factor of the Market

The biochemical reagents market is witnessing significant growth due to several key factors. Firstly, the rapid advancement in molecular biology techniques and their applications in healthcare have created a high demand for efficient and reliable reagents in laboratories worldwide. The rising prevalence of chronic diseases and the consequent need for diagnostic and therapeutic solutions are driving pharmaceutical companies to invest heavily in research and development, which in turn boosts the consumption of biochemical reagents. Secondly, the increasing applications of these reagents in agricultural biotech for enhancing crop yield and resistance to pests are expanding the market's scope. Furthermore, the growing trend of personalized medicine necessitates the use of specific reagents tailored for individual patient profiles, thereby fueling market demand. Lastly, the expansion of the biotechnology sector, particularly in emerging economies, presents lucrative opportunities for market players to penetrate new markets and expand their product offerings.

Key Highlights of the Market

• The biochemical reagents market is expected to reach USD 54 billion by 2035, reflecting a notable growth trajectory.
• A significant portion of the market growth is attributed to advancements in drug discovery and personalized medicine.
• Investment in research and development by pharmaceutical and biotechnology companies remains a primary driver of market dynamics.
• The rise of automation in laboratories is anticipated to enhance the efficiency of biochemical assays and reduce operational costs.
• Emerging markets in Asia Pacific are expected to witness the highest growth rates due to increased investments in life sciences and biotechnology.

By Product Type

Enzymes:

Enzymes constitute a critical segment of the biochemical reagents market, primarily used as catalysts in various biochemical reactions. These reagents play a vital role in drug discovery, diagnostic tests, and research applications. The market for enzyme-based reagents is driven by their high specificity and efficiency, making them an integral part of molecular biology and biochemistry. Innovations in enzyme engineering are leading to the development of more robust and versatile enzymes, which are expected to expand their applications across multiple industries. Additionally, as the demand for high-quality and reliable enzymatic assays increases, particularly in clinical diagnostics and pharmaceutical research, the enzyme segment is anticipated to witness substantial growth over the forecast period.

Antibodies:

Antibodies are among the most widely used biochemical reagents, playing a crucial role in various applications such as immunoassays, diagnostics, and therapeutic development. The market for antibodies is primarily driven by the increasing need for reliable diagnostic tests, particularly in the context of infectious diseases and autoimmune disorders. Furthermore, advancements in antibody engineering, such as the development of monoclonal and polyclonal antibodies, have led to enhanced specificity and sensitivity in assays. The growing pharmaceutical and biotechnology sectors continue to invest in research activities involving antibodies, thereby supporting market growth. As personalized medicine evolves, the demand for customized antibody reagents is expected to surge, providing significant opportunities for market players.

Nucleic Acids:

Nucleic acids, including DNA and RNA, are essential components of molecular biology research and diagnostics, responsible for carrying genetic information. The growing popularity of techniques such as PCR, qPCR, and next-generation sequencing is significantly contributing to the demand for nucleic acid-based reagents. Their applications in genetic testing, gene therapy, and personalized medicine are expanding rapidly, thereby enhancing their market presence. Additionally, the rise in research activities related to genomics and proteomics is expected to drive the nucleic acids segment's growth. The development of synthetic nucleic acids and advances in nucleic acid delivery systems are also anticipated to bolster the market for nucleic acid reagents.

Buffers:

Buffers are critical components in biochemical experiments, providing a stable pH environment necessary for various biochemical reactions to occur smoothly. The market for buffer solutions is driven by their extensive applications in molecular biology, biochemistry, and analytical chemistry. As research activities across various sectors continue to expand, the demand for high-quality buffer solutions, which help maintain optimal conditions for enzymatic and chemical reactions, is on the rise. Additionally, the trend towards standardization in laboratory practices is expected to lead to increased consumption of commercially available buffer systems, thereby enhancing market growth. Innovations in buffer formulations tailored for specific applications are set to further drive demand for this product type.

Stains and Dyes:

Stains and dyes are vital reagents used in microscopy, histology, and cytology for visualizing biological specimens. The growing emphasis on research and development in the life sciences, coupled with advancements in imaging technologies, is propelling the demand for high-quality stains and dyes. These reagents are essential for various applications, including cell biology, histopathology, and environmental studies, where they aid in the identification and characterization of cell types and structures. The increasing focus on cancer research and the need for effective diagnostic tools are further driving the market for stains and dyes. As new formulations and applications are developed, the stains and dyes segment is expected to experience significant growth in the coming years.

By Application

Drug Discovery:

The drug discovery application segment is one of the most significant contributors to the biochemical reagents market. The increasing prevalence of chronic diseases, coupled with the continuous need for novel therapeutic agents, drives pharmaceutical and biotechnology companies to invest heavily in drug discovery processes. Biochemical reagents, including enzymes, antibodies, and nucleic acids, play a crucial role in screening potential drug candidates, optimizing lead compounds, and conducting pharmacokinetic and pharmacodynamic studies. As regulatory bodies emphasize the importance of rigorous testing and validation of new drugs, the demand for high-quality biochemical reagents is expected to increase substantially in this segment. Moreover, the advent of new technologies such as artificial intelligence and machine learning, which aid in drug design and discovery, is anticipated to further enhance the market for biochemical reagents in drug development.

Clinical Diagnosis:

The clinical diagnosis application segment is witnessing remarkable growth due to the rising demand for accurate and timely diagnostic tests. Biochemical reagents are integral to various diagnostic procedures, including immunoassays, PCR tests, and biochemical assays for detecting diseases. The increasing incidence of infectious diseases and the ongoing challenges posed by emerging pathogens have led to a surge in the development of diagnostic tools, thus driving the demand for biochemical reagents. Additionally, the trend towards point-of-care testing and home diagnostics has created a need for rapid and reliable reagents that can deliver accurate results within a short time frame. The ongoing advancements in diagnostic technologies and the growing focus on personalized medicine are further expected to bolster the market for biochemical reagents in clinical diagnostics.

Biotechnology:

The biotechnology application segment encompasses a wide range of processes, including genetic engineering, cell culture, and bioprocessing, which rely heavily on various biochemical reagents. The rapid expansion of the biotechnology sector, driven by advancements in genomics, proteomics, and synthetic biology, is significantly boosting the demand for biochemical reagents. Researchers in academia and industry require high-quality enzymes, nucleic acids, and antibodies to conduct experiments and develop new biotechnological products. The increasing investment in research and development activities, particularly in emerging fields such as gene editing and regenerative medicine, is anticipated to drive the growth of this segment. As biotechnological applications continue to evolve, the need for innovative and versatile biochemical reagents will remain a key driver of market expansion.

Academic Research:

Academic research is a prominent segment in the biochemical reagents market, with universities and research institutions relying heavily on these reagents for various scientific investigations. The growing focus on basic and applied research across multiple disciplines, including biology, chemistry, and environmental science, is driving the demand for high-quality biochemical reagents. Increased funding from government and private sectors for research initiatives is further facilitating growth in this segment. As researchers seek to explore new scientific frontiers and address global challenges, the need for innovative biochemical reagents that support advanced research methodologies will continue to rise. Collaborations between academia and industry are expected to lead to the development of novel reagents and technologies, thus benefiting the overall market.

Agriculture:

The agricultural application segment of the biochemical reagents market is gaining traction as the focus on sustainable agriculture and food security intensifies. Biochemical reagents are utilized in various agricultural applications, including soil analysis, pest management, and crop improvement research. The increasing awareness of the need for environmentally friendly agricultural practices is driving the demand for biochemical solutions that enhance crop yield and resistance to diseases. The integration of molecular biology techniques in agriculture, such as genetic modification and molecular markers, further fuels the demand for specific biochemical reagents tailored for agricultural applications. As research in agricultural biotechnology continues to advance, the market for biochemical reagents in this segment is anticipated to see significant growth.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel in the biochemical reagents market, allowing manufacturers to engage directly with customers, including research institutions, hospitals, and pharmaceutical companies. This channel offers several advantages, such as personalized service, direct feedback from end-users, and better control over pricing strategies. Direct sales enable manufacturers to build strong relationships with their clients and provide tailored solutions that meet specific research needs. As the demand for customized biochemical reagents increases, the direct sales channel is expected to grow, helping companies to establish themselves as preferred partners in the research community. The trend of establishing dedicated sales teams to cater to scientific and research audiences is anticipated to enhance the effectiveness of this distribution channel.

Distributors:

Distributors play a crucial role in the biochemical reagents market by serving as intermediaries between manufacturers and end-users. They provide convenient access to a wide range of products, helping research institutions and laboratories source the reagents they need efficiently. The distributor network allows manufacturers to reach diverse geographical markets without incurring the costs associated with direct sales. Moreover, distributors often provide value-added services such as technical support, logistics, and inventory management, which can enhance the overall customer experience. As the demand for biochemical reagents continues to grow, the role of distributors is expected to expand, with companies increasingly leveraging these networks to penetrate new markets and facilitate customer access.

By User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are among the largest consumers of biochemical reagents, utilizing them extensively in research and development activities. The growing focus on drug discovery and development initiatives necessitates the use of various reagents for screening, assay development, and quality control. As these companies strive to innovate and create new therapeutic solutions, the demand for high-quality and reliable biochemical reagents remains substantial. Additionally, as personalized medicine trends continue to gain momentum, the specificity and performance of biochemical reagents become even more critical. The ongoing advancements in pharmaceutical research, coupled with an increasing number of biotech startups, are expected to drive growth in this user segment significantly.

Academic & Research Institutes:

Academic and research institutes are significant users of biochemical reagents, relying on them for various scientific investigations across multiple disciplines. The growing emphasis on research and development, coupled with increased funding for scientific studies, is enhancing the demand for these reagents. Universities and research institutes utilize biochemical reagents for teaching, basic research, and applied sciences, with a wide range of applications in molecular biology, biochemistry, and environmental science. Collaborations between academic institutions and industry partners further boost the consumption of biochemical reagents, as research outcomes often lead to product development and innovation. As educational institutions expand their research capabilities, the market for biochemical reagents catering to this user segment is expected to flourish.

Hospitals & Diagnostic Centers:

Hospitals and diagnostic centers are vital users of biochemical reagents, employing these products in various diagnostic tests and clinical applications. The increasing demand for accurate and timely diagnostic solutions, particularly in the context of disease outbreaks and chronic illnesses, is driving the growth of this user segment. Biochemical reagents are essential for performing immunoassays, PCR tests, and enzyme-linked immunosorbent assays (ELISA), among others. As healthcare providers strive to enhance patient care and outcomes, the reliance on high-quality biochemical reagents becomes paramount. The trend towards point-of-care testing and the growing focus on preventive healthcare are also anticipated to drive the demand for biochemical reagents in hospitals and diagnostic centers significantly.

By Region

The regional analysis of the biochemical reagents market reveals a dynamic landscape, with North America holding the largest market share, accounting for approximately 40% of the global market. The region's dominance can be attributed to the presence of established pharmaceutical and biotechnology companies, robust research infrastructure, and significant investments in research and development. Furthermore, the increasing incidence of chronic diseases and the need for advanced diagnostic solutions are propelling the market in North America. The CAGR for this region is projected to be around 6.5% during the forecast period, driven by continuous technological advancements and the growing focus on personalized medicine.

Europe is the second-largest market for biochemical reagents, comprising about 30% of the global share. The region's strong focus on research and innovation, coupled with an increasing number of partnerships between academic institutions and industry players, supports the demand for biochemical reagents. The rising prevalence of infectious diseases and the growing emphasis on precision medicine are also contributing to market growth in Europe. The Asia Pacific region is expected to witness the highest growth rate, with a CAGR of 8% during the forecast period, driven by increasing investments in healthcare and biotechnology, a burgeoning population, and rising demand for advanced diagnostic solutions. Latin America and the Middle East & Africa are also expected to see gradual growth, supported by an increasing focus on healthcare improvements and research initiatives.

Opportunities

The biochemical reagents market presents numerous opportunities for growth and expansion, particularly in emerging economies. As these regions continue to invest in healthcare and biotechnology, the demand for high-quality biochemical reagents is expected to rise significantly. This growth is driven by increasing research activities in universities and research institutions, where the need for reliable reagents for experimentation and analysis is paramount. Additionally, as governments and private organizations emphasize the importance of health research and the development of new diagnostic tools, market players have the opportunity to establish themselves in these burgeoning markets, providing innovative and customized products tailored to local needs. Collaborations with local entities and adapting product offerings to meet regional regulatory requirements can further enhance market penetration.

Moreover, the continuous evolution of technology in the life sciences sector presents significant opportunities for biochemical reagent manufacturers. The advent of automation in laboratories and advancements in biotechnology techniques, such as CRISPR and next-generation sequencing, create a growing demand for specialized reagents that cater to these applications. Companies that invest in research and development to create novel and high-performance biochemical reagents stand to gain a competitive advantage in the marketplace. Furthermore, the trend towards personalized medicine is opening new avenues for growth, as there is an increasing need for customized reagents that can be tailored to individual patient profiles. By focusing on innovation and leveraging emerging technologies, industry players can capitalize on the rising opportunities in the biochemical reagents market.

Threats

Despite the promising growth prospects, the biochemical reagents market faces several threats that could impede its progress. The stringent regulatory environment governing the approval and use of biochemical reagents can pose significant challenges for manufacturers. The need for extensive testing and validation to meet regulatory standards can lead to increased production costs and longer timeframes for product launches. Additionally, the rapidly changing landscape of the biotechnology and pharmaceutical industries means that companies must constantly innovate to keep pace with new scientific advancements and technologies. Failure to adapt to these changes could result in a loss of market share to more agile and innovative competitors.

Another significant threat is the potential for market consolidation through mergers and acquisitions, which may limit competition and reduce the diversity of available products. As larger companies acquire smaller biotech firms, there is a risk that niche products and specialized reagents could be discontinued or deprioritized, leading to a homogenization of offerings. Moreover, supply chain disruptions, particularly in the wake of global events such as pandemics or geopolitical tensions, could affect the availability and pricing of raw materials needed for the production of biochemical reagents. Such disruptions may lead to fluctuations in market stability and pricing pressures, challenging manufacturers to maintain their profitability.

Competitor Outlook

• Thermo Fisher Scientific
• Merck KGaA
• Agilent Technologies
• Biocon
• Roche
• Bio-Rad Laboratories
• Sigma-Aldrich (part of Merck Group)
• GE Healthcare
• PerkinElmer
• Danaher Corporation
• Qiagen N.V.
• Fisher Scientific
• Zymo Research Corporation
• New England BioLabs
• Tecan Group

The competitive landscape of the biochemical reagents market is characterized by the presence of several key players, each striving to enhance their market position through innovation, product development, and strategic collaborations. Major companies such as Thermo Fisher Scientific and Merck KGaA dominate the market, offering a comprehensive range of biochemical reagents and services to meet the diverse needs of researchers and laboratories. These companies invest significantly in research and development, focusing on the creation of high-performance reagents tailored for specific applications. Additionally, they often engage in strategic partnerships with research institutions and biotechnology firms to advance their product offerings and expand their market reach.

Agilent Technologies and Roche are also notable competitors in the biochemical reagents market, known for their cutting-edge technologies and commitment to quality. Agilent focuses on providing innovative solutions across various applications, including genomics, proteomics, and diagnostics, while Roche's extensive portfolio includes a wide range of reagents for clinical diagnostics and research. Both companies leverage their strong research capabilities to introduce novel products that cater to evolving market demands. Furthermore, the increasing trend of mergers and acquisitions among these players is reshaping the competitive landscape, as companies seek to enhance their capabilities and expand their product lines through strategic acquisitions.

Emerging players such as Zymo Research Corporation and New England BioLabs are also making significant strides in the biochemical reagents market, offering specialized products that cater to niche applications. These companies are focusing on innovation and quality to differentiate themselves from established competitors. They aim to capitalize on the increasing demand for specialized reagents in areas such as molecular biology and synthetic biology. As the market continues to evolve, the competitive dynamics will likely shift, with companies exploring new collaborations, product lines, and technologies to stay ahead of the curve. Overall, the biochemical reagents market remains highly competitive, with various players seeking to capitalize on growth opportunities while navigating the challenges posed by an ever-changing landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Roche
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Biocon
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 PerkinElmer
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Qiagen N.V.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Tecan Group
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 GE Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Fisher Scientific
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Danaher Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 New England BioLabs
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Zymo Research Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sigma-Aldrich (part of Merck Group)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Biochemical Reagents Market, By User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Academic & Research Institutes
    • 6.1.3 Hospitals & Diagnostic Centers
  • 6.2 Biochemical Reagents Market, By Application
    • 6.2.1 Drug Discovery
    • 6.2.2 Clinical Diagnosis
    • 6.2.3 Biotechnology
    • 6.2.4 Academic Research
    • 6.2.5 Agriculture
  • 6.3 Biochemical Reagents Market, By Product Type
    • 6.3.1 Enzymes
    • 6.3.2 Antibodies
    • 6.3.3 Nucleic Acids
    • 6.3.4 Buffers
    • 6.3.5 Stains and Dyes
  • 6.4 Biochemical Reagents Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributors

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Biochemical Reagents Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Biochemical Reagents market is categorized based on

By Product Type

• Enzymes
• Antibodies
• Nucleic Acids
• Buffers
• Stains and Dyes

By Application

• Drug Discovery
• Clinical Diagnosis
• Biotechnology
• Academic Research
• Agriculture

By Distribution Channel

• Direct Sales
• Distributors

By User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Centers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• Agilent Technologies
• Biocon
• Roche
• Bio-Rad Laboratories
• Sigma-Aldrich (part of Merck Group)
• GE Healthcare
• PerkinElmer
• Danaher Corporation
• Qiagen N.V.
• Fisher Scientific
• Zymo Research Corporation
• New England BioLabs
• Tecan Group